Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets

This publication has 11 references indexed in Scilit:

• Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist
  Inflammation Research, 1982
• DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS
  The Lancet, 1981
• Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors
  Life Sciences, 1981
• Serotonin binding in human platelets
  Biochemical Pharmacology, 1979
• Relative activities on and uptake by human blood platelets of 5‐hydroxytryptamine and several analogues
  British Journal of Pharmacology, 1972
• The release of nucleotides, 5‐hydroxytryptamine and enzymes from human blood platelets during aggregation
  The Journal of Physiology, 1968
• Effects of 5-Hydroxytryptamine on Platelet Aggregation
  Nature, 1968
• Membrane Active Drugs and the Aggregation of Human Blood Platelets
  Nature, 1967
• Platelet Clumping in vitro
  British Journal of Haematology, 1964
• Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets
  Nature, 1961